In the BioHarmony Drug Report Database

"Preview" Icon

Ferric maltol

Accrufer, Feraccru (ferric maltol) is a small molecule pharmaceutical. Ferric maltol was first approved as Accrufer on 2016-02-18. It has been approved in Europe to treat iron-deficiency anemia. Accrufer’s patent is valid until 2035-10-23 (FDA).

 

Trade Name

 

Feraccru
 

Common Name

 

ferric maltol
 

ChEMBL ID

 

CHEMBL4298110
 

Indication

 

iron-deficiency anemia
 

Drug Class

 

Hematologic agents

Image (chem structure or protein)

Ferric maltol structure rendering